Peter Salzmann
Chief Executive Officer, Immunovant, Inc.
Companies
- Immunovant, Inc.Board member Dec 20, 2019 to now1
- Immunovant, Inc.Chief executive officer Dec 20, 2019 to Jul 30, 20251
- Corbus PharmaceuticalsBoard member Mar 10, 2020 to Jun 3, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Immunovant, Inc. IMVT1,178,191 shares3$32.4M at $27.51Apr 16, 2025
Corbus Pharmaceuticals CRBP2,783 shares4$12.6K at $4.52May 30, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 16, 2025Sold 8,321 shares at $14.89 of Immunovant, Inc.3
- Apr 9, 2025Sold 28,094 shares at $12.99 of Immunovant, Inc.5
- Apr 1, 2025Granted 265,820 shares of Immunovant, Inc.6
- Feb 19, 2025Sold 15,439 shares at $20.86 of Immunovant, Inc.7
- Jan 15, 2025Sold 415 shares at $24.19 of Immunovant, Inc.8
- Jan 15, 2025Sold 8,352 shares at $23.81 of Immunovant, Inc.8
- Jan 8, 2025Sold 5,105 shares at $24.10 of Immunovant, Inc.9
- Nov 20, 2024Sold 16,692 shares at $25.45 of Immunovant, Inc.10
- Oct 16, 2024Sold 9,095 shares at $28.79 of Immunovant, Inc.11
- Oct 9, 2024Sold 4,460 shares at $29.56 of Immunovant, Inc.12
- Aug 21, 2024Sold 598 shares at $32.32 of Immunovant, Inc.13
- Aug 21, 2024Sold 14,470 shares at $31.84 of Immunovant, Inc.13
- Jul 17, 2024Sold 510 shares at $30.55 of Immunovant, Inc.14
- Jul 17, 2024Sold 8,175 shares at $29.64 of Immunovant, Inc.14
- Jul 9, 2024Sold 4,619 shares at $28.06 of Immunovant, Inc.15
- May 30, 2024Granted 2,783 shares of Corbus Pharmaceuticals4
- May 22, 2024Sold 16,163 shares at $29.65 of Immunovant, Inc.16
- Apr 17, 2024Sold 7,714 shares at $29.94 of Immunovant, Inc.17
- Apr 17, 2024Sold 26,365 shares at $28.80 of Immunovant, Inc.17
- Apr 9, 2024Sold 4,807 shares at $31.18 of Immunovant, Inc.18
- Apr 2, 2024Granted 160,534 shares of Immunovant, Inc.19
- Feb 22, 2024Sold 13,454 shares at $36.15 of Immunovant, Inc.20
- Jan 5, 2024Sold 3,824 shares at $38.59 of Immunovant, Inc.21
- Nov 22, 2023Sold 616 shares at $33.52 of Immunovant, Inc.22
- Nov 22, 2023Sold 15,601 shares at $32.75 of Immunovant, Inc.22
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARImmunovant, Inc., Board member
- 2SEC EDGARCorbus Pharmaceuticals, Board member
- 3
- 4
- 5SEC EDGARForm 4 filed Apr 11, 2025
- 6SEC EDGARForm 4 filed Apr 3, 2025
- 7SEC EDGARForm 4 filed Feb 21, 2025
- 8SEC EDGARForm 4 filed Jan 17, 2025
- 9SEC EDGARForm 4 filed Jan 10, 2025
- 10SEC EDGARForm 4 filed Nov 22, 2024
- 11SEC EDGARForm 4 filed Oct 18, 2024
- 12SEC EDGARForm 4 filed Oct 11, 2024
- 13SEC EDGARForm 4 filed Aug 23, 2024
- 14SEC EDGARForm 4 filed Jul 19, 2024
- 15SEC EDGARForm 4 filed Jul 10, 2024
- 16SEC EDGARForm 4 filed May 24, 2024
- 17SEC EDGARForm 4 filed Apr 19, 2024
- 18SEC EDGARForm 4 filed Apr 10, 2024
- 19SEC EDGARForm 4 filed Apr 4, 2024
- 20SEC EDGARForm 4 filed Feb 23, 2024
- 21SEC EDGARForm 4 filed Jan 9, 2024
- 22SEC EDGARForm 4 filed Nov 24, 2023